Definium Therapeutics is advancing its pivotal Phase 3 Voyage trial in generalized anxiety disorder, a key step for its late-stage psychiatric pipeline, followi

BWB News TV • 2026-08-13 17:16 UTC • By Billy Odell Tucker-Robinson

Definium Therapeutics is advancing its pivotal Phase 3 Voyage trial in generalized anxiety disorder, a key step for its late-stage psychiatric pipeline, following earlier positive Phase 3 data for DT120 ODT.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly